Here, the PD1/PD‐L1 profile of DFs fell into the group defined ‘the noninflamed tumor type’, which is closely associated with the EMT/STEM‐like type controlled by oncogenic and epigenetic pathways including β‐catenin, and is predictive of no clinical response of DFs to immune‐based therapies (Zou et al., 2016). Here, CD274 is linked to neoplasm.